SSIQX | TRWTX | SSIQX / TRWTX | |
Total Expense Ratio | 0.75 | 0.76 | 99% |
Annual Report Gross Expense Ratio | 1.01 | 0.76 | 133% |
Fund Existence | 11 years | 33 years | - |
Gain YTD | 32.811 | 25.171 | 130% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 188M | 4.49B | 4% |
Annual Yield % from dividends | 2.96 | 2.22 | 133% |
Returns for 1 year | 28.33 | 18.55 | 153% |
Returns for 3 years | 93.35 | 71.99 | 130% |
Returns for 5 years | 88.49 | 64.96 | 136% |
Returns for 10 years | 96.45 | 74.00 | 130% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FATEX | 129.96 | 0.29 | +0.22% |
Fidelity Advisor Technology M | |||
EMFIX | 13.73 | 0.03 | +0.22% |
Ashmore Emerging Markets Equity Instl | |||
VKSAX | 19.62 | -0.06 | -0.30% |
Virtus KAR Small-Mid Cap Core A | |||
LYFCX | 14.08 | -0.08 | -0.56% |
AlphaCentric Life Sciences & Hlthcare C | |||
NQVAX | 60.13 | -0.87 | -1.43% |
Nuveen Multi Cap Value A |